Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis. 1988

H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
Department of Pathology, University of Limburg, Maastricht, The Netherlands.

A radiochemical oestrogen receptor assay on cytosol was correlated with a radiochemical and an immunohistochemical oestrogen receptor assay using cryostat sections from 50 breast cancer specimens. Oestrogen receptors were reliably quantitated in 6 micron cryostat sections with Scatchard analysis using radiolabelled oestradiol, and a good quantitative and qualitative relation with cytosol oestrogen receptor assay was found. Parallel sections were used for routine histological tissue verification and for direct comparison with immunohistochemistry for oestrogen receptor. Specific immunoperoxidase staining with a rat monoclonal antibody was scored by semiquantitative evaluation of the staining intensity of cancer cell nuclei. Oestrogen receptor scoring was highly reproducible when performed by the same observer. The semiquantitative immunohistochemical oestrogen receptor score correlated significantly better with the radiochemical assay on sections than with cytosol assay. Oestrogen receptor in breast cancer can be reliably assayed by semiquantitative evaluation of cryostat sections immunostained for oestrogen receptor, but only if the procedure is adequately standardised. The results underline the importance of cellular heterogeneity as a cause of variation in oestrogen receptor assay evaluation in breast cancer.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
April 1983, Journal of clinical pathology,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
August 1984, Journal of steroid biochemistry,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
May 1986, British journal of cancer,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
June 1994, British journal of cancer,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
December 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
June 1987, Clinica chimica acta; international journal of clinical chemistry,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
January 1995, Acta neurochirurgica,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
January 1986, Journal of clinical pathology,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
December 1999, Cytometry,
H M Scheres, and A F De Goeij, and M J Rousch, and G G Hondius, and D D Willebrand, and A H Gijzen, and F T Bosman
October 1989, Journal of clinical pathology,
Copied contents to your clipboard!